{'fraction_non_alphanumeric': 0.028827674567584883, 'fraction_numerical': 0.020499679692504803, 'mean_word_length': 6.1981566820276495, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Benzoic acid production via cascade biotransformation and coupled fermentation‐biotransformation

As an important bulk chemical, benzoic acid is currently manufactured from nonrenewable feedstocks under harsh conditions. Although there are natural pathways for biosynthesis of benzoic acid, they are often inefficient and subjected to complex regulation. Here we develop a nonnatural enzyme cascade to efficiently produce benzoic acid from styrene or biogenic L‐phenylalanine under mild conditions. By using a modular approach, two whole‐cell catalysts Escherichia coli LZ305 and LZ325 are engineered for coexpressing seven and nine enzymes for production of 133–146 mM benzoic acid (16.2–17.8 g/Laq) with 88–97% conversion via seven‐ and nine‐step cascade biotransformation of styrene and L‐phenylalanine, respectively. The seven‐step cascade represents a formal high‐yielding biocatalytic oxidative cleavage of styrene, and the nine‐step cascade showcases the high efficiency of extended nonnatural enzyme cascades. Moreover, to achieve benzoic acid production directly from low‐cost renewable glycerol, a novel coupled fermentation‐biotransformation process was developed by integration of fermentative production of L‐phenylalanine with in situ biotransformation to give 63–70 mM benzoic acid (7.6–8.6 g/Laq), which is around 20 times higher than the reported value via a natural pathway. The coupled fermentation‐biotransformation process could be generally applicable to microbial production of growth‐inhibitory or toxic chemicals in high concentrations.